Trials / Not Yet Recruiting
Not Yet RecruitingNCT06549504
Bioequivalence Study of AG2202
An Open-label, Randomized, Fasting, Single, Oral Administration, Group 2, Stage 2, Cross-over Bioequivalence Study of AG2202 in Healthy Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.
Detailed description
To evaluate the bioequivalence of two formulations of AG2202T and AG2202R after a single oral dose administration in healthy Korean subjects under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG2202T | AG2202T Single-dose |
| DRUG | AG2202R | AG2202R Single-dose |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2024-08-12
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT06549504. Inclusion in this directory is not an endorsement.